Chemed Corp banner

Chemed Corp
NYSE:CHE

Watchlist Manager
Chemed Corp Logo
Chemed Corp
NYSE:CHE
Watchlist
Price: 421.11 USD 9.96% Market Closed
Market Cap: $5.8B

EV/S

2.3
Current
35%
Cheaper
vs 3-y average of 3.5

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
2.3
=
Enterprise Value
$5.2B
/
Revenue
$2.5B

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
2.3
=
Enterprise Value
$5.2B
/
Revenue
$2.5B

Valuation Scenarios

Chemed Corp is trading below its 3-year average

If EV/S returns to its 3-Year Average (3.5), the stock would be worth $650.56 (54% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-8%
Maximum Upside
+54%
Average Upside
33%
Scenario EV/S Value Implied Price Upside/Downside
Current Multiple 2.3 $421.11
0%
3-Year Average 3.5 $650.56
+54%
5-Year Average 3.4 $640.79
+52%
Industry Average 2.1 $386.37
-8%
Country Average 3 $567.78
+35%

Forward EV/S
Today’s price vs future revenue

Today's Enterprise Value Revenue Forward EV/S
$5.2B
/
Jan 2026
$2.5B
=
2.3
Current
$5.2B
/
Dec 2026
$2.7B
=
1.9
Forward
$5.2B
/
Dec 2027
$2.9B
=
1.8
Forward
$5.2B
/
Dec 2028
$3B
=
1.7
Forward

Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
EV/S
P/E
All Countries
Close

Market Distribution

In line with most companies in the United States of America
Percentile
40th
Based on 11 256 companies
40th percentile
2.3
Low
0 — 1.6
Typical Range
1.6 — 5.3
High
5.3 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 1.6
Median 3
70th Percentile 5.3
Max 4 613 320.1

Chemed Corp
Glance View

Chemed Corporation, a somewhat enigmatic yet resolutely steadfast entity, operates in the realms of hospice care and plumbing services, a duality that intrigues analysts and investors alike. Established through strategic foresight, Chemed has crafted a remarkably resilient business model by housing two distinct subsidiaries under its corporate umbrella: VITAS Healthcare and Roto-Rooter. VITAS Healthcare, which still stands as the nation's largest provider of end-of-life care, dominates the hospice sector by offering comprehensive palliative care services right at the patients' doorstep, aiming to ensure dignity and comfort during life's final stages. This subsidiary capitalizes on a combination of Medicare and Medicaid reimbursements as well as private insurances, which form the backbone of its revenue stream. Meanwhile, Roto-Rooter, a company with a name synonymous with plumbing repair and maintenance, fortifies Chemed's revenue streams through an entirely different channel. Known as a household name across America, Roto-Rooter offers an extensive range of services from emergency plumbing repair to water cleanup and restoration. With its franchise model combined with company-operated branches, Roto-Rooter generates income primarily through service fees. The dual nature of Chemed’s operational style—a blend of healthcare sensitivity and industrial pragmatism—not only ensures diversified income avenues but also exemplifies a pragmatic approach to risk management. This business strategy, deftly combining distinct yet robust sectors, allows Chemed to weather economic fluctuations that might impact one industry but not the other, ultimately creating a stable financial foundation for the company.

CHE Intrinsic Value
485.51 USD
Undervaluation 13%
Intrinsic Value
Price $421.11
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett